APA (7th ed.) Citation

Lahu, S., Ndrepepa, G., Neumann, F., Menichelli, M., Bernlochner, I., Richardt, G., . . . Kastrati, A. (2022). Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes: A subgroup analysis of the ISAR-REACT 5 trial : original article : acute coronary syndromes. European heart journal - cardiovascular pharmacotherapy, 8(7), . https://doi.org/10.1093/ehjcvp/pvac007

Chicago Style (17th ed.) Citation

Lahu, Shqipdona, et al. "Pre-admission Antiplatelet Therapy and Treatment Effect of Ticagrelor Vs. Prasugrel in Patients with Acute Coronary Syndromes: A Subgroup Analysis of the ISAR-REACT 5 Trial : Original Article : Acute Coronary Syndromes." European Heart Journal - Cardiovascular Pharmacotherapy 8, no. 7 (2022). https://doi.org/10.1093/ehjcvp/pvac007.

MLA (9th ed.) Citation

Lahu, Shqipdona, et al. "Pre-admission Antiplatelet Therapy and Treatment Effect of Ticagrelor Vs. Prasugrel in Patients with Acute Coronary Syndromes: A Subgroup Analysis of the ISAR-REACT 5 Trial : Original Article : Acute Coronary Syndromes." European Heart Journal - Cardiovascular Pharmacotherapy, vol. 8, no. 7, 2022, https://doi.org/10.1093/ehjcvp/pvac007.